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Collagen, the most abundant component of extracellular matrix, is a mole-
cule of choice for the development of cellular biomaterials, because it can
interact with most cell types and can facilitate their adhesion and growth. In
this study, electrospun nanofibrous collagen patches was used to provide a
biocompatible physical support for the graft of human pluripotent stem cells
derived cardiomyocytes (hPCS-CM) for the treatment of the failing heart.
Different types of clinically approved collagen were studied for their ability
to form high quality uniform fibers by electrospinning using a benign solvent
system based on ethanol, water and salts. Atelocollagen – that contains 95% of
type I and 5% of type III – exhibited the best performance. After appropriate
crosslinking using cytocompatible agents based on citric acid (concentrated to
5% or 10%), the collagen was placed to special holders for cell culture.
The electrospun collagen patches were used for culture of newborn rats cardio-
myocytes, showing regular beating after 3 days of culture. They already have been
successfully used for the culture of hPSC-CM. Finally, the electrospun collagen
patches have been implanted in mice with dilated cardiomyopathy and have exhi-
bited excellent biocompatibility. Cardiac function measured by echocardiography
before and after the graft, histological, and molecular studies showed no detri-
mental effects of the collagen scaffold. Our next target is the implantation of
hPSC-CM-seeded scaffold in mice with dilated cardiomyopathy.
0202
Adult cardiomyocytes proliferation blockage by nuclear ephrin-B1:
involvement of the PI3Kγ pathway
Marie Cauquil (1), Céline Mias (1), Marie-Hélène Séguélas (1), Céline
Guilbeau-Frugier (2), Adrien Lupieri (1), Muriel Laffargue (1), Atul
Pathak (3), Jean-Michel Sénard (3), Céline Galés (1)
(1) CHU Toulouse Rangueil, I2MC, Toulouse, France – (2) CHU Tou-
louse, Histopathologie, Toulouse, France – (3) CHU Toulouse, Pharma-
cologie clinique, Toulouse, France
The possibility to reboot the proliferation of adult resident cardiomyocytes
(CMs) has emerged as a promising avenue in cardiac regenerative medicine. For
that purpose, there is an urgent need for identifying the molecular mechanisms
involved in the natural blockage of adult CMs proliferation. Recently, we
recently demonstrated that ephrin-B1 expression in the CMs nuclei acts as a spe-
cific inhibitor of the adult CMs proliferation (unpublished data). Here, we have
explored the specific role of the PI3Kγ  in the nuclearization of ephrin-B1.
Fluorescent immunostaining showed a specific loss of nuclear ephrin-B1 in
p110-γ  KO but not in KI mice, suggesting a specific role of the PKA-
anchoring function of the p110-γ  catalytic subunit of PI3Kγ  in ephrin-B1
nuclearization. Interestingly, p110-γ  KO mice demonstrated a significant
increase of mononucleated CMs (19,1 ± 1,1 % vs 13,3 ± 1,0 % in WT) cor-
related to a decrease in binucleated CMs (70,9 ± 1,9 % vs 79,7 ±1,0 % in WT)
possibly indicative of a proliferative potential. In agreement with a prolifera-
tive potential, we measured a higher level of replicative-BrdU+ CMs in KO
PI3Kγ  mice (WT: 6,23±2,2 % ; KO: 19,3±4,9 %; KI: 3,0±0,8 %), but also a
higher CMs density in cardiac tissue from 8 month old mice (WT:
2633±79,4cm/mm²; KO: 3208±155,6CM/mm²; KI: 2659,7±99,3CM/mm²)
mosy likely reflecting CMs hyperplasia. To confirm the involvement of a
cAMP/PKA pathway in ephrin-B1 nuclearization, we studied a neonatal car-
diomyoblast cell line (H9C2) naturally expressing a nuclear ephrin-B1 pool.
We showed that H89 treatment prevented ephrin-B1 nuclearization while for-
skolin promoted nuclearization of a recombinant ephrin-B1-GFP.
These results demonstrated for the first time the specific role of the cAMP/
PKA/PI3Kγ  pathway in ephrin-B1 nuclearization in the CM. In the future, the
accurate characterization of this pathway could allow identifying new and
more specific targets for heart regenerative medicine strategies.
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Human pluripotent stem cells derived cardiomyoctyes are one the most
promising cells for cardiac research, i.e. disease modeling, drug screening and
cell therapy applications. Obtaining these cells is a critical step and has been
the subject of many studies and publications. Recent advances in this field
have shown that a sequential activation and inhibition of the Wnt pathway
induces the differentiation of human pluripotent stem cells toward the cardiac
lineage. This procedure can be achieved in a chemically-defined environment,
and beating cells are obtained after 8 days.
Several parameters of this protocol could still be improved. For example,
the small molecules used (Wnt activators and inhibitors) are not approved by
the health authorities, preventing their use in clinical studies. Moreover, there
are no standard procedures to recover the cardiomyocytes after the differenti-
ation protocol. Finally, late-stage differentiation to a totally matured ventri-
cular cardiomyocyte population has not been achieved for the moment. The
immature cardiac cells obtained have several differences compared to adult
cardiomyocytes. There are, for example, mismatches in cell size and shape,
gap junction, alignment and calcium handling ability. Raise these technolog-
ical barriers could lead to new perspectives in the use of these cells.
Our studies in this area have led us to develop innovative strategies to
obtain, recover and to mature these cells. We have tested several FDA-
approved drugs known to modulate the Wnt pathway in order to obtain a clin-
ical-grade population cardiomyocytes. We also determined, using a combina-
tion of protease, the condition of recovery allowing the best survival rate and
function of these cells. Finally, we improve the maturity of cardiomyocytes
derived from pluripotent stem cells by tuning their micro-environment. Our
results demonstrate the importance of the extracellular matrix composition and
mechanical properties.
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The possibility to reboot the proliferation of adult resident cardiomyo-
cytes (CM) has recently emerged as a new promising avenue in cardiac
regenerative medicine. For that purpose, there is an urgent need for identi-
fying the molecular mechanisms involved in the natural blockage of adult
CM proliferation.
We recently identified ephrin-B1 as specific stabilizer of the CM rod-shape
allowing the cardiac tissue cohesion. Interestingly, we found that ephrin-B1
knock-out mice (KO) compensate aging stress through a surprising CM hyper-
plasia, suggesting an atypical proliferation of adult CM. Cell cycle genes pro-
filing performed by qRT-PCR showed that old KO CM significantly up-
regulated genes involved in all cell cycle phases. Progression of CM
throughout the cell cycle was confirmed by flow cytometry and revealed the
presence of the replicative S-phase only in old KO CM. Proliferation was next
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